Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma
- 31 October 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (11) , 1900-1902
- https://doi.org/10.1016/s0959-8049(97)00263-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Combination of chemotherapy and recombinant interferon-alpha in advanced non-small cell lung cancerCancer Letters, 1997
- A phase I trial of 5-day continuous infusion cisplatin and interferon αCancer Chemotherapy and Pharmacology, 1995
- A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinomaAnnals of Oncology, 1995
- A phase I trial of 5-day continuous infusion cisplatin and interferon ?Cancer Chemotherapy and Pharmacology, 1995
- Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer: Multicentric randomized FONICAP trial reportCancer, 1993
- Phase II study of continuous subcutaneous interferon-alfa combined with cisplatin in advanced malignant melanomaEuropean Journal Of Cancer, 1992
- A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinumInvestigational New Drugs, 1991
- Original article: Potentiation of cisplatin by alpha-Interferon in advanced non-small cell lung cancer (NSCLC): A phase II studyAnnals of Oncology, 1990